| APO-LEVOTHYROXINE (100 MCG) | 02534681 | Marketed | Apotex Inc. | Mar 2025 |
| APO-LEVOTHYROXINE (300 MCG) | 02534703 | Marketed | Apotex Inc. | Mar 2025 |
| APO-LEVOTHYROXINE (25 MCG) | 02550709 | Marketed | Apotex Inc. | Mar 2025 |
| APO-LEVOTHYROXINE (50 MCG) | 02550717 | Marketed | Apotex Inc. | Mar 2025 |
| APO-LEVOTHYROXINE (75 MCG) | 02550725 | Marketed | Apotex Inc. | Mar 2025 |
| APO-LEVOTHYROXINE (88 MCG) | 02550733 | Marketed | Apotex Inc. | Mar 2025 |
| APO-LEVOTHYROXINE (112 MCG) | 02550741 | Marketed | Apotex Inc. | Mar 2025 |
| APO-LEVOTHYROXINE (125 MCG) | 02550768 | Marketed | Apotex Inc. | Mar 2025 |
| APO-LEVOTHYROXINE (137 MCG) | 02550776 | Marketed | Apotex Inc. | Mar 2025 |
| APO-LEVOTHYROXINE (150 MCG) | 02550784 | Marketed | Apotex Inc. | Mar 2025 |
| APO-LEVOTHYROXINE (175 MCG) | 02550792 | Marketed | Apotex Inc. | Mar 2025 |
| APO-LEVOTHYROXINE (200 MCG) | 02550806 | Marketed | Apotex Inc. | Mar 2025 |
| ELTROXIN (50 MCG) | 02213192 | Marketed | Aspen Pharmacare Canada Inc. | Mar 2018 |
| ELTROXIN (100 MCG) | 02213206 | Marketed | Aspen Pharmacare Canada Inc. | Apr 2018 |
| ELTROXIN (150 MCG) | 02213214 | Marketed | Aspen Pharmacare Canada Inc. | Apr 2018 |
| ELTROXIN (200 MCG) | 02213222 | Marketed | Aspen Pharmacare Canada Inc. | Oct 2017 |
| LEVOTHYROXINE SODIUM FOR INJECTION (500 MCG) | 02245948 | Marketed | Fresenius Kabi Canada Ltd | Jan 2016 |
| LEVOTHYROXINE SODIUM FOR INJECTION (200 MCG) | 02461714 | Marketed | Avir Pharma Inc | Nov 2019 |
| LEVOTHYROXINE SODIUM FOR INJECTION (500 MCG) | 02461722 | Marketed | Avir Pharma Inc | Sep 2018 |
| LEVOTHYROXINE SODIUM INJECTION (40 MCG) | 02499916 | Marketed | Fresenius Kabi Canada Ltd | Jun 2022 |
| LEVOTHYROXINE SODIUM INJECTION (100 MCG) | 02499924 | Marketed | Fresenius Kabi Canada Ltd | Jun 2022 |
| SYNTHROID (50 MCG) | 02172070 | Marketed | BGP Pharma ULC | Mar 2016 |
| SYNTHROID (25 MCG) | 02172062 | Marketed | BGP Pharma ULC | Mar 2016 |
| SYNTHROID (112 MCG) | 02171228 | Marketed | BGP Pharma ULC | Mar 2016 |
| SYNTHROID (125 MCG) | 02172119 | Marketed | BGP Pharma ULC | Mar 2016 |
| SYNTHROID (75 MCG) | 02172089 | Marketed | BGP Pharma ULC | Mar 2016 |
| SYNTHROID (300 MCG) | 02172151 | Marketed | BGP Pharma ULC | Aug 2016 |
| SYNTHROID (200 MCG) | 02172143 | Marketed | BGP Pharma ULC | Mar 2016 |
| SYNTHROID (150 MCG) | 02172127 | Marketed | BGP Pharma ULC | Mar 2016 |
| SYNTHROID (88 MCG) | 02172097 | Marketed | BGP Pharma ULC | Apr 2016 |
| SYNTHROID (175 MCG) | 02172135 | Marketed | BGP Pharma ULC | Mar 2016 |
| SYNTHROID (100 MCG) | 02172100 | Marketed | BGP Pharma ULC | Mar 2016 |
| SYNTHROID (137 MCG) | 02233852 | Marketed | BGP Pharma ULC | Mar 2016 |
| THYCONVI (20 MCG) | 02568373 | Marketed | BioSyent Pharma Inc. | May 2026 |
| THYRO-TABS CANINE (0.1 MG) | 02231021 | Marketed | Lloyd Inc. Of Iowa | Sep 2017 |
| THYRO-TABS CANINE (0.2 MG) | 02231022 | Marketed | Lloyd Inc. Of Iowa | Sep 2017 |
| THYRO-TABS CANINE (0.3 MG) | 02231023 | Marketed | Lloyd Inc. Of Iowa | Sep 2017 |
| THYRO-TABS CANINE (0.4 MG) | 02231024 | Marketed | Lloyd Inc. Of Iowa | Sep 2017 |
| THYRO-TABS CANINE (0.5 MG) | 02231025 | Marketed | Lloyd Inc. Of Iowa | Sep 2017 |
| THYRO-TABS CANINE (0.6 MG) | 02231026 | Marketed | Lloyd Inc. Of Iowa | Sep 2017 |
| THYRO-TABS CANINE (0.7 MG) | 02231027 | Marketed | Lloyd Inc. Of Iowa | Sep 2017 |
| THYRO-TABS CANINE (0.8 MG) | 02231028 | Marketed | Lloyd Inc. Of Iowa | Sep 2017 |
| ELTROXIN (25 MCG) | 02559919 | Approved | Aspen Pharmacare Canada Inc. | Jul 2025 |
| ELTROXIN (75 MCG) | 02559927 | Approved | Aspen Pharmacare Canada Inc. | Jul 2025 |
| ELTROXIN (88 MCG) | 02559935 | Approved | Aspen Pharmacare Canada Inc. | Jul 2025 |
| ELTROXIN (112 MCG) | 02559943 | Approved | Aspen Pharmacare Canada Inc. | Jul 2025 |
| ELTROXIN (125 MCG) | 02559951 | Approved | Aspen Pharmacare Canada Inc. | Jul 2025 |
| ELTROXIN (137 MCG) | 02559978 | Approved | Aspen Pharmacare Canada Inc. | Jul 2025 |
| ELTROXIN (175 MCG) | 02559986 | Approved | Aspen Pharmacare Canada Inc. | Jul 2025 |
| LEVOTHYROXINE SODIUM FOR INJECTION (200 MCG) | 02245947 | Approved | Fresenius Kabi Canada Ltd | Apr 2015 |
| SOLOXINE (LEVOTHRYOXINE SODIUM TABLETS 0.8MG) (.8 MG) | 02158566 | Dormant | Virbac Ah, Inc. | Jul 2018 |
| SOLOXINE (LEVOTHYROXINE SODIUM TABLETS 0.1MG) (.1 MG) | 02158515 | Dormant | Virbac Ah, Inc. | Jul 2018 |
| SOLOXINE (LEVOTHYROXINE SODIUM TABLETS 0.2MG) (.2 MG) | 02158523 | Dormant | Virbac Ah, Inc. | Jul 2018 |
| SOLOXINE (LEVOTHYROXINE SODIUM TABLETS 0.3MG) (.3 MG) | 02158531 | Dormant | Virbac Ah, Inc. | Jul 2018 |
| SOLOXINE (LEVOTHYROXINE SODIUM TABLETS 0.5MG) (.5 MG) | 02158558 | Dormant | Virbac Ah, Inc. | Jul 2018 |
| ELTROXIN (300 MCG) | 02213230 | Cancelled Post Market | Aspen Pharmacare Canada Inc. | Sep 2018 |
| ELTROXIN 150 TAB (150 MCG) | 00295582 | Cancelled Post Market | Glaxo Canada Inc | Aug 1999 |
| ELTROXIN TAB 100MCG (.1 MG) | 00012297 | Cancelled Post Market | Glaxo Canada Inc | Aug 1999 |
| ELTROXIN TAB 200MCG (.2 MG) | 00012300 | Cancelled Post Market | Glaxo Canada Inc | Jul 1998 |
| ELTROXIN TAB 300MCG (.3 MG) | 00012319 | Cancelled Post Market | Glaxo Canada Inc | Jul 1998 |
| ELTROXIN TAB 50MCG (0.05 MG) | 00012289 | Cancelled Post Market | Glaxo Canada Inc | Jul 1998 |
| EUTHYROX (25 MCG) | 02264323 | Cancelled Post Market | Emd Serono A Division Of Emd Inc Canada | Feb 2026 |
| EUTHYROX (50 MCG) | 02264331 | Cancelled Post Market | Emd Serono A Division Of Emd Inc Canada | Feb 2026 |
| EUTHYROX (75 MCG) | 02264358 | Cancelled Post Market | Emd Serono A Division Of Emd Inc Canada | Feb 2026 |
| EUTHYROX (88 MCG) | 02264366 | Cancelled Post Market | Emd Serono A Division Of Emd Inc Canada | Feb 2026 |
| EUTHYROX (100 MCG) | 02264374 | Cancelled Post Market | Emd Serono A Division Of Emd Inc Canada | Feb 2026 |
| EUTHYROX (112 MCG) | 02264390 | Cancelled Post Market | Emd Serono A Division Of Emd Inc Canada | Feb 2026 |
| EUTHYROX (125 MCG) | 02264404 | Cancelled Post Market | Emd Serono A Division Of Emd Inc Canada | Feb 2026 |
| EUTHYROX (137 MCG) | 02264412 | Cancelled Post Market | Emd Serono A Division Of Emd Inc Canada | Feb 2026 |
| EUTHYROX (150 MCG) | 02264420 | Cancelled Post Market | Emd Serono A Division Of Emd Inc Canada | Feb 2026 |
| EUTHYROX (175 MCG) | 02264439 | Cancelled Post Market | Emd Serono A Division Of Emd Inc Canada | Feb 2026 |
| EUTHYROX (200 MCG) | 02264447 | Cancelled Post Market | Emd Serono A Division Of Emd Inc Canada | Feb 2026 |
| EUTHYROX (300 MCG) | 02264455 | Cancelled Post Market | Emd Serono A Division Of Emd Inc Canada | Apr 2026 |
| LEVENTA (1 MG) | 02429438 | Cancelled Post Market | Intervet Canada Corp | Mar 2023 |
| LEVO-T 100MCG - TAB (100 MCG) | 02187604 | Cancelled Post Market | Pharmascience Inc. | Jun 2006 |
| LEVO-T 125MCG - TAB (125 MCG) | 02187612 | Cancelled Post Market | Pharmascience Inc. | Jun 2006 |
| LEVO-T 150MCG - TAB (150 MCG) | 02187620 | Cancelled Post Market | Pharmascience Inc. | Jun 2006 |
| LEVO-T 200MCG - TAB (200 MCG) | 02187639 | Cancelled Post Market | Pharmascience Inc. | Jun 2006 |
| LEVO-T 25MCG - TAB (25 MCG) | 02187574 | Cancelled Post Market | Pharmascience Inc. | Jun 2006 |
| LEVO-T 300MCG - TAB (300 MCG) | 02187647 | Cancelled Post Market | Pharmascience Inc. | Jun 2006 |
| LEVO-T 50MCG - TAB (50 MCG) | 02187582 | Cancelled Post Market | Pharmascience Inc. | Jun 2006 |
| LEVO-T 75MCG - TAB (75 MCG) | 02187590 | Cancelled Post Market | Pharmascience Inc. | Jun 2006 |
| LEVOTEC 100MCG TABLETS USP (100 MCG) | 02237216 | Cancelled Post Market | Technilab Pharma Inc. | Jul 2004 |
| LEVOTEC 112MCG TABLETS USP (112 MCG) | 02237217 | Cancelled Post Market | Technilab Pharma Inc. | Jul 2004 |
| LEVOTEC 125MCG TABLETS USP (125 MCG) | 02237218 | Cancelled Post Market | Technilab Pharma Inc. | Jul 2004 |
| LEVOTEC 150MCG TABLETS USP (150 MCG) | 02237219 | Cancelled Post Market | Technilab Pharma Inc. | Jul 2004 |
| LEVOTEC 175MCG TABLETS USP (175 MCG) | 02237220 | Cancelled Post Market | Technilab Pharma Inc. | Jul 2004 |
| LEVOTEC 200MCG TABLETS USP (200 MCG) | 02237221 | Cancelled Post Market | Technilab Pharma Inc. | Jul 2004 |
| LEVOTEC 25MCG TABLETS USP (25 MCG) | 02237213 | Cancelled Post Market | Technilab Pharma Inc. | Jul 2004 |
| LEVOTEC 300MCG TABLETS USP (300 MCG) | 02237222 | Cancelled Post Market | Technilab Pharma Inc. | Jul 2004 |
| LEVOTEC 50MCG TABLETS USP (50 MCG) | 02237214 | Cancelled Post Market | Technilab Pharma Inc. | Jul 2004 |
| LEVOTEC 75MCG TABLETS USP (75 MCG) | 02237215 | Cancelled Post Market | Technilab Pharma Inc. | Jul 2004 |
| NV-THYRO (0.1 MG) | 02238429 | Cancelled Post Market | Novopharm Limited | Oct 2015 |
| NV-THYRO (0.2 MG) | 02238430 | Cancelled Post Market | Novopharm Limited | Oct 2015 |
| NV-THYRO (0.3 MG) | 02238431 | Cancelled Post Market | Novopharm Limited | Oct 2015 |
| NV-THYRO (0.4 MG) | 02238432 | Cancelled Post Market | Novopharm Limited | Oct 2015 |
| NV-THYRO (0.5 MG) | 02238433 | Cancelled Post Market | Novopharm Limited | Oct 2015 |
| NV-THYRO (0.6 MG) | 02238434 | Cancelled Post Market | Novopharm Limited | Oct 2015 |
| NV-THYRO (0.7 MG) | 02238435 | Cancelled Post Market | Novopharm Limited | Oct 2015 |
| NV-THYRO (0.8 MG) | 02238436 | Cancelled Post Market | Novopharm Limited | Oct 2015 |
| PMS-LEVOTHYROXINE SODIUM TAB 100MCG (100 MCG) | 01953621 | Cancelled Post Market | Pharmascience Inc. | Aug 1998 |
| PMS-LEVOTHYROXINE SODIUM TAB 125MCG (125 MCG) | 01953656 | Cancelled Post Market | Pharmascience Inc. | Aug 1998 |
| PMS-LEVOTHYROXINE SODIUM TAB 150MCG (150 MCG) | 01953664 | Cancelled Post Market | Pharmascience Inc. | Aug 1998 |
| PMS-LEVOTHYROXINE SODIUM TAB 200MCG (200 MCG) | 01953680 | Cancelled Post Market | Pharmascience Inc. | Aug 1998 |
| PMS-LEVOTHYROXINE SODIUM TAB 25MCG (25 MCG) | 01953591 | Cancelled Post Market | Pharmascience Inc. | Aug 1998 |
| PMS-LEVOTHYROXINE SODIUM TAB 300MCG (300 MCG) | 01953699 | Cancelled Post Market | Pharmascience Inc. | Aug 1998 |
| PMS-LEVOTHYROXINE SODIUM TAB 50MCG (50 MCG) | 01953605 | Cancelled Post Market | Pharmascience Inc. | Aug 1998 |
| PMS-LEVOTHYROXINE SODIUM TAB 75MCG (75 MCG) | 01953613 | Cancelled Post Market | Pharmascience Inc. | Aug 1998 |
| SYNTHROID LIQ INJ 500MCG/VIAL USP (500 MCG) | 01981013 | Cancelled Post Market | Boots Pharmaceuticals Ltd. | Sep 1996 |
| SYNTHROID TAB 100MCG USP (100 MCG) | 01980955 | Cancelled Post Market | Boots Pharmaceuticals Ltd. | Sep 1996 |
| SYNTHROID TAB 112MCG USP (112 MCG) | 01980947 | Cancelled Post Market | Boots Pharmaceuticals Ltd. | Sep 1996 |
| SYNTHROID TAB 125MCG USP (125 MCG) | 01980939 | Cancelled Post Market | Boots Pharmaceuticals Ltd. | Sep 1996 |
| SYNTHROID TAB 150MCG USP (150 MCG) | 01980920 | Cancelled Post Market | Boots Pharmaceuticals Ltd. | Sep 1996 |
| SYNTHROID TAB 175MCG USP (175 MCG) | 01980912 | Cancelled Post Market | Boots Pharmaceuticals Ltd. | Sep 1996 |
| SYNTHROID TAB 200MCG USP (200 MCG) | 01980904 | Cancelled Post Market | Boots Pharmaceuticals Ltd. | Sep 1996 |
| SYNTHROID TAB 25MCG USP (25 MCG) | 01981005 | Cancelled Post Market | Boots Pharmaceuticals Ltd. | Sep 1996 |
| SYNTHROID TAB 300MCG TAB (300 MCG) | 01980890 | Cancelled Post Market | Boots Pharmaceuticals Ltd. | Sep 1996 |
| SYNTHROID TAB 50MCG USP (50 MCG) | 01980998 | Cancelled Post Market | Boots Pharmaceuticals Ltd. | Sep 1996 |
| SYNTHROID TAB 75MCG USP (75 MCG) | 01980971 | Cancelled Post Market | Boots Pharmaceuticals Ltd. | Sep 1996 |
| SYNTHROID TAB 88MCG USP (88 MCG) | 01980963 | Cancelled Post Market | Boots Pharmaceuticals Ltd. | Sep 1996 |
| THYRO-FORM CHEWABLE TABLETS 0.2MG (0.2 MG) | 02231445 | Cancelled Post Market | Vet A Mix Inc. | Apr 2001 |
| THYRO-FORM CHEWABLE TABLETS 0.5MG (0.5 MG) | 02231446 | Cancelled Post Market | Vet A Mix Inc. | Apr 2001 |
| THYRO-FORM CHEWABLE TABLETS 0.8MG (0.8 MG) | 02231447 | Cancelled Post Market | Vet A Mix Inc. | Dec 2001 |
| THYROKARE (0.1 MG) | 02532743 | Cancelled Pre Market | Neogen Corporation | Jul 2024 |
| THYROKARE (0.2 MG) | 02532751 | Cancelled Pre Market | Neogen Corporation | Jul 2024 |
| THYROKARE (0.3 MG) | 02532778 | Cancelled Pre Market | Neogen Corporation | Jul 2024 |
| THYROKARE (0.4 MG) | 02532786 | Cancelled Pre Market | Neogen Corporation | Jul 2024 |
| THYROKARE (0.5 MG) | 02532794 | Cancelled Pre Market | Neogen Corporation | Jul 2024 |
| THYROKARE (0.6 MG) | 02532808 | Cancelled Pre Market | Neogen Corporation | Jul 2024 |
| THYROKARE (0.7 MG) | 02532816 | Cancelled Pre Market | Neogen Corporation | Jul 2024 |
| THYROKARE (0.8 MG) | 02532824 | Cancelled Pre Market | Neogen Corporation | Jul 2024 |
| THYROKARE (1 MG) | 02532832 | Cancelled Pre Market | Neogen Corporation | Jul 2024 |
| TIROCAP (13 MCG) | 02508486 | Cancelled Pre Market | Ibsa Institut Biochimique Sa | Mar 2024 |
| TIROCAP (25 MCG) | 02508494 | Cancelled Pre Market | Ibsa Institut Biochimique Sa | Mar 2024 |
| TIROCAP (50 MCG) | 02508508 | Cancelled Pre Market | Ibsa Institut Biochimique Sa | Mar 2024 |
| TIROCAP (75 MCG) | 02508516 | Cancelled Pre Market | Ibsa Institut Biochimique Sa | Mar 2024 |
| TIROCAP (88 MCG) | 02508524 | Cancelled Pre Market | Ibsa Institut Biochimique Sa | Mar 2024 |
| TIROCAP (100 MCG) | 02508532 | Cancelled Pre Market | Ibsa Institut Biochimique Sa | Mar 2024 |
| TIROCAP (112 MCG) | 02508540 | Cancelled Pre Market | Ibsa Institut Biochimique Sa | Mar 2024 |
| TIROCAP (125 MCG) | 02508559 | Cancelled Pre Market | Ibsa Institut Biochimique Sa | Mar 2024 |
| TIROCAP (137 MCG) | 02508567 | Cancelled Pre Market | Ibsa Institut Biochimique Sa | Mar 2024 |
| TIROCAP (150 MCG) | 02508575 | Cancelled Pre Market | Ibsa Institut Biochimique Sa | Mar 2024 |
| TIROCAP (175 MCG) | 02508583 | Cancelled Pre Market | Ibsa Institut Biochimique Sa | Mar 2024 |
| TIROCAP (200 MCG) | 02508591 | Cancelled Pre Market | Ibsa Institut Biochimique Sa | Mar 2024 |